IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Amphastar Pharmaceuticals, Inc. & Advises Investors w...
December 28 2016 - 11:40AM
Business Wire
Goldberg Law PC, a national shareholder rights litigation firm,
announces that it is investigating Amphastar Pharmaceuticals, Inc.
(“Amphastar” or the “Company”) (Nasdaq: AMPH) concerning possible
violations of federal securities laws.
If you purchased or otherwise acquired Amphastar shares and
would like more information regarding the investigation, we
encourage you to contact Michael Goldberg or Brian Schall, of
Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles,
CA 90067, at 800-977-7401, to discuss your rights without cost to
you. You can also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
Armstrong Pharmaceuticals, Inc. ("Armstrong"), a subsidiary
company of Amphastar, received notice from the U.S. Food and Drug
Administration ("FDA") that Armstrong’s New Drug Application for
Primatene Mist, used as an epinephrine inhalation aerosol product,
was not approved.
The FDA found issues with the product’s packaging and label. The
FDA further encouraged Armstrong to conduct another Human Factor
validation study to measure consumers' ability to independently use
the product.
When this information was disclosed to the public, Amphastar
stock fell in value, causing investors serious harm.
If you have any questions concerning your legal rights, please
immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com, or email us at
info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161228005349/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.com
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Sep 2023 to Sep 2024